Literature DB >> 25948744

Characterization of the Human Papillomavirus 16 E8 Promoter.

Elke Straub1, Jasmin Fertey1, Marcel Dreer1, Thomas Iftner1, Frank Stubenrauch2.   

Abstract

UNLABELLED: Persistent infections with certain human papillomaviruses (HPV) such as HPV16 are a necessary risk factor for the development of anogenital and oropharyngeal cancers. HPV16 genomes replicate as low-copy-number plasmids in the nucleus of undifferentiated keratinocytes, which requires the viral E1 and E2 replication proteins. The HPV16 E8^E2C (or E8^E2) protein limits genome replication by repressing both viral transcription and the E1/E2-dependent DNA replication. How E8^E2C expression is regulated is not understood. Previous transcript analyses indicated that the spliced E8^E2C RNA is initiated at a promoter located in the E1 region upstream of the E8 gene. Deletion and mutational analyses of the E8 promoter region identify two conserved elements that are required for basal promoter activity in HPV-negative keratinocytes. In contrast, the transcriptional enhancer in the upstream regulatory region of HPV16 does not modulate basal E8 promoter activity. Cotransfection studies indicate that E8^E2C inhibits, whereas E2 weakly activates, the E8 promoter. Interestingly, the cotransfection of E1 and E2 induces the E8 promoter much more strongly than the major early promoter, and this is partially dependent upon binding of E2 to Brd4. Mutation of E8 promoter elements in the context of HPV16 genomes results in an increased genome copy number and elevated levels of viral early and late transcripts. In summary, the promoter responsible for the expression of E8^E2C is both positively and negatively regulated by viral and cellular factors, and this regulatory circuit may be crucial to maintain a low but constant copy number of HPV16 genomes in undifferentiated cells. IMPORTANCE: HPV16 replicates in differentiating epithelia and can cause cancer. How HPV16 maintains its genome in undifferentiated cells at a low but constant level is not well understood but may be relevant for the immunological escape of HPV16 in the basal layers of the infected epithelium. This study demonstrates that the expression of the viral E8^E2C protein, which is a potent inhibitor of viral replication in undifferentiated cells, is driven by a separate promoter. The E8 promoter is both positively and negatively regulated by viral proteins and thus most likely acts as a sensor and modulator of viral copy number.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25948744      PMCID: PMC4473580          DOI: 10.1128/JVI.00616-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  Initiation of DNA replication: lessons from viral initiator proteins.

Authors:  Arne Stenlund
Journal:  Nat Rev Mol Cell Biol       Date:  2003-10       Impact factor: 94.444

2.  Growth inhibition of HeLa cells is a conserved feature of high-risk human papillomavirus E8^E2C proteins and can also be achieved by an artificial repressor protein.

Authors:  Jasmin Fertey; José Hurst; Elke Straub; Astrid Schenker; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

3.  Carcinogenicity of human papillomaviruses.

Authors:  Vincent Cogliano; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi
Journal:  Lancet Oncol       Date:  2005-04       Impact factor: 41.316

4.  Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.

Authors:  Michal-Ruth Schweiger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

5.  Evidence supporting a role for TopBP1 and Brd4 in the initiation but not continuation of human papillomavirus 16 E1/E2-mediated DNA replication.

Authors:  Elaine J Gauson; Mary M Donaldson; Edward S Dornan; Xu Wang; Molly Bristol; Jason M Bodily; Iain M Morgan
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

6.  Inhibition of transcription and DNA replication by the papillomavirus E8-E2C protein is mediated by interaction with corepressor molecules.

Authors:  Ingo Ammermann; Markus Bruckner; Frank Matthes; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

7.  Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes.

Authors:  T M Tan; B Gloss; H U Bernard; R C Ting
Journal:  J Gen Virol       Date:  1994-10       Impact factor: 3.891

Review 8.  The papillomavirus E2 proteins.

Authors:  Alison A McBride
Journal:  Virology       Date:  2013-07-10       Impact factor: 3.616

9.  The transcription map of human papillomavirus type 18 during genome replication in U2OS cells.

Authors:  Mart Toots; Andres Männik; Gaily Kivi; Mart Ustav; Ene Ustav; Mart Ustav
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

Review 10.  Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle.

Authors:  Alison A McBride; Moon Kyoo Jang
Journal:  Viruses       Date:  2013-05-30       Impact factor: 5.048

View more
  14 in total

1.  Cottontail Rabbit Papillomavirus E1 and E2 Proteins Mutually Influence Their Subcellular Localizations.

Authors:  Markus Schneider; Aylin Yigitliler; Frank Stubenrauch; Thomas Iftner
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

2.  Identification and Functional Characterization of Phosphorylation Sites of the Human Papillomavirus 31 E8^E2 Protein.

Authors:  Saskia van de Poel; Marcel Dreer; Ana Velic; Boris Macek; Praveen Baskaran; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

3.  Interferon Kappa Inhibits Human Papillomavirus 31 Transcription by Inducing Sp100 Proteins.

Authors:  Christina Habiger; Günter Jäger; Michael Walter; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

4.  Interaction of NCOR/SMRT Repressor Complexes with Papillomavirus E8^E2C Proteins Inhibits Viral Replication.

Authors:  Marcel Dreer; Jasmin Fertey; Saskia van de Poel; Elke Straub; Johannes Madlung; Boris Macek; Thomas Iftner; Frank Stubenrauch
Journal:  PLoS Pathog       Date:  2016-04-11       Impact factor: 6.823

Review 5.  Control of human papillomavirus gene expression by alternative splicing.

Authors:  Sheila V Graham; Arwa Ali A Faizo
Journal:  Virus Res       Date:  2016-11-17       Impact factor: 3.303

6.  A new cell culture model to genetically dissect the complete human papillomavirus life cycle.

Authors:  Malgorzata Bienkowska-Haba; Wioleta Luszczek; Julia E Myers; Timothy R Keiffer; Stephen DiGiuseppe; Paula Polk; Jason M Bodily; Rona S Scott; Martin Sapp
Journal:  PLoS Pathog       Date:  2018-03-01       Impact factor: 6.823

Review 7.  The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer.

Authors:  Andrea Cerasuolo; Luigi Buonaguro; Franco M Buonaguro; Maria Lina Tornesello
Journal:  Front Cell Dev Biol       Date:  2020-06-12

8.  Stochastic modeling of human papillomavirusearly promoter gene regulation.

Authors:  Alberto Giaretta; Gianna Maria Toffolo; Timothy C Elston
Journal:  J Theor Biol       Date:  2019-10-28       Impact factor: 2.691

Review 9.  Keratinocyte Differentiation-Dependent Human Papillomavirus Gene Regulation.

Authors:  Sheila V Graham
Journal:  Viruses       Date:  2017-08-30       Impact factor: 5.048

Review 10.  Perspectives in HPV Secondary Screening and Personalized Therapy Basing on Our Understanding of HPV-Related Carcinogenesis Pathways.

Authors:  Aleksander Celewicz; Marta Celewicz; Michał Michalczyk; Rafał Rzepka
Journal:  Mediators Inflamm       Date:  2020-03-25       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.